AstraZeneca’s daily weight-loss pill elecoglipron delivers 11.8% body weight reduction in a Phase 2 trial, setting up a clash with Novo and Eli Lilly. 

Next weight-loss breakthrough? AstraZeneca tests a daily pill - Elecoglipron

oral-glp-1-drugs

Oral Glp 1 Drugs, News on Oral Glp 1 Drugs, stories on Oral Glp 1 Drugs, articles on Oral Glp 1 Drugs, Oral Glp 1 Drugs stories at Wion, Oral Glp 1 Drugs news, Oral Glp 1 Drugs latest news

oral glp-1-drugs

Next weight-loss breakthrough? AstraZeneca tests a daily pill - Elecoglipron